🇺🇸 FDA
Patent

US 7164000

RANTES mutants and therapeutic applications thereof

granted A61KA61K38/00A61P

Quick answer

US patent 7164000 (RANTES mutants and therapeutic applications thereof) held by FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
Grant date
Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P11/06, A61P29/00